| A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike S Xia, L Yan, W Xu, AS Agrawal, A Algaissi, CTK Tseng, Q Wang, L Du, ... Science advances 5 (4), eaav4580, 2019 | 497 | 2019 |
| Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience AA Algaissi, NK Alharbi, M Hassanain, AM Hashem Journal of infection and public health 13 (6), 834-838, 2020 | 405 | 2020 |
| Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus AS Agrawal, X Tao, A Algaissi, T Garron, K Narayanan, BH Peng, ... Human vaccines & immunotherapeutics 12 (9), 2351-2356, 2016 | 327 | 2016 |
| Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia A Alhazmi, E Alamer, D Daws, M Hakami, M Darraj, S Abdelwahab, ... Vaccines 9 (6), 674, 2021 | 154 | 2021 |
| Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review AM Hashem, BS Alghamdi, AA Algaissi, FS Alshehri, A Bukhari, ... Travel medicine and infectious disease 35, 101735, 2020 | 140 | 2020 |
| Viromimetic STING agonist‐loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus LCW Lin, CY Huang, BY Yao, JC Lin, A Agrawal, A Algaissi, BH Peng, ... Advanced functional materials 29 (28), 1807616, 2019 | 135 | 2019 |
| SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, ... Scientific reports 10 (1), 16561, 2020 | 101 | 2020 |
| Characterization and demonstration of the value of a lethal mouse model of Middle East respiratory syndrome coronavirus infection and disease X Tao, T Garron, AS Agrawal, A Algaissi, BH Peng, M Wakamiya, ... Journal of virology 90 (1), 57-67, 2016 | 85 | 2016 |
| Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement WH Chen, X Tao, AS Agrawal, A Algaissi, BH Peng, J Pollet, U Strych, ... Vaccine 38 (47), 7533-7541, 2020 | 75 | 2020 |
| Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen MP Nyon, L Du, CTK Tseng, CA Seid, J Pollet, KS Naceanceno, ... Vaccine 36 (14), 1853-1862, 2018 | 72 | 2018 |
| A highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human … AM Hashem, A Algaissi, AS Agrawal, SS Al-Amri, RY Alhabbab, ... The Journal of Infectious Diseases 220 (10), 1558-1567, 2019 | 63 | 2019 |
| Side effects of COVID-19 Pfizer-BioNtech mRNA vaccine in children aged 12–18 years in Saudi Arabia E Alamer, A Alhazmi, NA Qasir, R Alamer, H Areeshi, G Gohal, M Qadri, ... Vaccines 9 (11), 1297, 2021 | 60 | 2021 |
| Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular stomatitis … SA Almahboub, A Algaissi, MA Alfaleh, MZ ElAssouli, AM Hashem Frontiers in Microbiology 11, 2020, 2020 | 58 | 2020 |
| Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection AS Agrawal, T Ying, X Tao, T Garron, A Algaissi, Y Wang, L Wang, ... Scientific reports 6 (1), 31629, 2016 | 58 | 2016 |
| Early humoral response correlates with disease severity and outcomes in COVID-19 patients AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, ... Viruses 12 (12), 1390, 2020 | 54 | 2020 |
| Bacterial coinfections increase mortality of severely ill COVID-19 patients in Saudi Arabia A Alqahtani, E Alamer, M Mir, A Alasmari, MM Alshahrani, M Asiri, ... International Journal of Environmental Research and Public Health 19 (4), 2424, 2022 | 46 | 2022 |
| Evaluation of MERS-CoV neutralizing antibodies in sera using live virus microneutralization assay A Algaissi, AM Hashem MERS Coronavirus: Methods and Protocols, 107-116, 2020 | 44 | 2020 |
| Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with alum induces protective immunity and reduces immune enhancement WH Chen, X Tao, A Agrawal, A Algaissi, BH Peng, J Pollet, U Strych, ... bioRxiv, 2020.05. 15.098079, 2020 | 35 | 2020 |
| Nationwide seroprevalence of SARS-CoV-2 in Saudi arabia NK Alharbi, S Alghnam, A Algaissi, H Albalawi, MW Alenazi, ... Journal of infection and public health 14 (7), 832-838, 2021 | 33 | 2021 |
| Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to Middle East respiratory syndrome coronavirus infection and disease A Algaissi, AS Agrawal, S Han, BH Peng, C Luo, F Li, TS Chan, RB Couch, ... The Journal of Infectious Diseases 219 (5), 829-835, 2019 | 29 | 2019 |
